patent foramen ovale PFO PFO 1990 PFO PFO Amplatzer PFO
|
|
|
- あいね なかじゅく
- 7 years ago
- Views:
Transcription
1
2 patent foramen ovale PFO PFO 1990 PFO PFO Amplatzer PFO
3 CQ 1 50 B patent foramen ovale PFO migraine with aura MA PFO migraine without aura MO 20 2,444 PFO 2016 MA MO MA PFO 50 MA PFO 2008 Schwedt PFO OR OR CI PFO MA 54.8 MO 30.0 p ,101 PFO 14.6 vs 15MA MO 19 vs PFO PFO 5, 6 CQ 1 3
4 1 Tariq N, Tepper SJ, Kriegler JS : Patent foramen ovale and migraine : closing the debate A review. Headache 2016 ; 56 3 : Schwedt TJ, Demaerschalk BM, Dodick DW : Patent foramen ovale and migraine : a quantitative systematic review. Cephalalgia 2008 ; 28 5 : Iwasaki A, Suzuki K, Takekawa H, Takashima R, Suzuki A, Suzuki S, Hirata K : Prevalence of right to left shunts in Japanese patients with migraine : a single center study. Intern Med 2017 ; : Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, Homma S : Patent foramen ovale and migraine : a cross sectional study from the Northern Manhattan Study NOMAS. Circulation 2008 ; : Anzola GP, Morandi E, Casilli F, Onorato E : Different degrees of right to left shunting predict migraine and stroke : data from 420 patients. Neurology 2006 ; 66 5 : Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, Seiler C : Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005 ; 65 9 : DB Pubmed 2016/2/6 Migraine patent foramen ovale 465 4
5 CQ 2 OR CI B CQ1 patent foramen ovale PFO PFO migraine with aura MA 14 2,602 PFO MA Schwedt PFO OR OR CI PFO MA OR CI OR 1 Tariq N, Tepper SJ, Kriegler JS : Patent foramen ovale and migraine : closing the debate A review. Headache 2016 ; 56 3 : Schwedt TJ, Demaerschalk BM, Dodick DW : Patent foramen ovale and migraine : a quantitative systematic review. Cephalalgia 2008 ; 28 5 : CQ 2 5
6 DB Pubmed 2016/2/6 Migraine patent foramen ovale 465 6
7 CQ 3 B patent foramen ovale PFO migraine with aura MA PFO PFO 20 1,194 PFO PFO PFO 19 Amplatzer RCT PFO 1 MIST 2 PFO MA STARFlex 74 sham P 0.51 CQ 3 7
8 2 PRIMA MA Amplatzer PFO P P PREMIUM Amplatzer PFO 107 sham /3 MA P P RCT PFO 1 Tariq N, Tepper SJ, Kriegler JS : Patent foramen ovale and migraine : closing the debate A review. Headache 2016 ; 56 3 : Takaya Y, Akagi T, Kijima Y, Nakagawa K, Kono S, Deguchi K, Sano S, Ito H : Influence of transcatheter closure of atrial communication on migraine headache in patients with ischemic stroke. Cardiovasc Interv Ther Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick Smith D, Elrington G, Hillis WS, Malik IS, Rickards A : Migraine Intervention With STARFlex Technology MIST trial : a prospective, multicenter, double blind, sham controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 ; : Mattle HP, Evers S, Hildick Smith D, Becker WJ, Baumgartner H, Chataway J, Gawel M, Göbel H, Heinze A, Horlick E, Malik I, Ray S, Zermansky A, Findling O, Windecker S, Meier B : Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J 2016 ; : Charles A, Silberstein S, Sorensen S, Maini B, Horwitz P, Gurley J, Tobis J. Results of the PREMIUM trial : patent foramen ovale closure with the AMPLATZER TM PFO occlude for the prevention of migraine. Headache 2015 ; 55 S5 : 251. DB Pubmed 2016/2/6 Migraine patent foramen ovale closure 250 8
9 CQ 4 A patent foramen ovale PFO 2016 PFO Amplatzer PFO FDA PFO MIST STARFlex Amplatzer PFO FDA Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick Smith D, Elrington G, Hillis WS, Malik IS, Rickards A : Migraine Intervention With STARFlex Technology MIST trial: a prospective, multicenter, double blind, sham controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 ; : MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM pdf#search=%27amplatzer+PFO+occlu der%27 CQ 4 9
10 DB Pubmed 2016/2/6 1. patent foramen ovale clsore adverse events Amplatzer PFO occlude adverse events 21 10
11 CQ B patent foramen ovale PFO PFO atrial septal defect ASD 10 2, 3 PFO ASD 2, ASD 171 CANOA vs PFO RCT 2 CANOA 4, 5 2, 3 CQ 5 11
12 1 Tariq N, Tepper SJ, Kriegler JS. Patent foramen ovale and migraine : closing the debate A review. Headache 2016 ; 56 3 : Kato Y, Kobayashi T, Ishido H, Hayashi T, Furuya D, Tanahashi N : Migraine attacks after transcatheter closure of atrial septal defect. Cephalalgia 2013 ; : Rodés Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Côté M, Marsal JR, Rivest D, Marrero A, Houde C : Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure : The CANOA Randomized Clinical Trial. JAMA 2015 ; : Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick Smith D, Elrington G, Hillis WS, Malik IS, Rickards A : Migraine Intervention With STARFlex Technology MIST trial : a prospective, multicenter, double blind, sham controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008 ; : Charles A, Silberstein S, Sorensen S, Maini B, Horwitz P, Gurley J, Tobis J : Results of the PREMIUM trial: patent foramen ovale closure with the AMPLATZER TM PFO occlude for the prevention of migraine. Headache 2015 ; 55 S5 : 251. DB Pubmed 2016/2/6 1. patent foramen ovale clsore clopidogrel atrial septal defect clopidogrel 11 12
164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10
163 特 集 SDD & SOD SDD(Selective digestive decontamination),sod(selective oropharynx decontamination), 腸内細菌叢, 耐性菌 Ⅰ はじめに SDD Selective digestive decontamination SOD Selective oropharynx decontamination
C/NC : committed/noncommitted
C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
日本化学療法学会雑誌第66巻第2号
173 Table 1.Detection rates of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Haemophilus influenzae and adenovirus from male urethritis in Urethritis No.
E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
JAGES 1 http://www.mlit.go.jp/common/000135841.pdf http://www.mhlw.go.jp/file/04-houdouhappyou-12004000-shakaiengokyoku-shakai-fukushikibanka/270624houdou.pdf_2.pdf 21 59 10 vs 9 8,500 8,000 7,500 7,000
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi
36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81
9 CQ 1 80 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 81 CQ 2 82 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 83 84 CQ 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 85 CQ 4
< E8AFA D8FC78CA48B8689EF5F4E6F2E31352E626F6F6B>
CADASIL MRI Clinical manifestation and MRI findings in Japanese patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). * * CADASIL (cerebral
2
1 2 3 15 4 1 15 1 31 3 15 1 162 272 CPA 46 28 CPA 1 CPA 4 CPA 5 a. ( ) ACLS 15 5 17 b. 1 12 c. 25 29 6 7 8 CPA CPA 1 CPA Randomized Controlled Trial, RCT RCT CPA CPA 1 Dr 9 CPA CPA 15 4 1 15 1 31 CPA CPA
_02.indd
30, 11-16, 2010 Z Z score Computed tomography ROC analysis 3 CT 1,2 CT 1/3 3 5 CT CT 6 7,8 MCA ASPECTS Alberta Stroke Programme Early CT Score 4 10 CT ASPECTS 50% 9 Z 10 CT Z CT 10 Z Z Z receiver operating
PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article 1 1. 2. MeSH Browser MeSH PreMEDLINE MeSH -2-
PubMed MEDLINE NLM 1879 Index Medicus 1960 MEDLARS Medical Literature Analysis and Retrieval System 1970 MEDLINE MEDlars online 1966 70 4,000 170 PubMed MEDLINE NLM National Center for Biotechnology Information
001-007 扉・口絵・目次
1 6 6 7 1 a a a a 2 a a a 3 4 5 a 6 7 8 9 10 a 11 a a a 12 13 14 15 a 16 17 18 19 20 21 22 23 24 b b 25 b 26 27 aa 28 r r 29 a s d f 30 b b 31 32 33 1 34 35 36 37 38 6 39 6 40 41 42 43 44 45 7 47 48
特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
東洋医学雑誌
Vol.67 No.2 123-130, 2016 Akiyo GUSHI a Chihaya KORIYAMA b Ryo YOSHINAGA c Hiromi YANO c Junichi TSUMAGARI d Eiichi TAHARA c a Gushi Dermatological Clinic, 45-3 Higashiohsyoji, Satsumasendai city, Kagoshima
【知事入れ版】270804_鳥取県人口ビジョン素案
7 6 5 4 3 2 1 65 1564 14 192 193 194 195 196 197 198 199 2 21 22 23 24 1.65 1,4 1.6 1,2 1.55 1, 1.45 6 1.5 8 1.4 4 1.35 1.3 2 27 28 29 21 211 212 213 214 6 5 4 3 2 1 213 218 223 228 233 238 243 248 253
1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):
Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 8 (2010) Key words Neuropsychopharmacology Neuroscientist Curr Opin Neurol Clin Rehabil J Neurol Neurosurg Psychiatry
1000
1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 SL 1000 1000 1000 1000 1000 1000 1000 1000 1000 ( 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
2013 5
12 (SL) (L) (SL) 2013 5 5 29 () 4 ( ) 7 17 20 ( ) 2 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 14. 4.17 14. 5. 1 14. 5. 8 14. 5.22 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 4 10 7 7 10 7 31 8 14.4.10 14.7.10 14.7.31
2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
.T.C.Y._.E..
25 No.33 C O N T E N T S REVIEW 1 2 5 4 3 6 7 8 9 1 11 1, 1, 7,5 75 916,95 (121) 756,67 (15) 718,89 (13) 91,496 (169) 54,2 (179) 3,243 (75) 727,333 (129) 564,47 (112) 55,458 (11) 6,68,953 (18) 5,624,957
valiant_captivia_product_catalog
SETTLE FOR NOTHING LESS VALIANT CAPTIVIA BARE STENT TYPE FREEFLO VALIANT Captivia FREEFLOはチップキャプチャーシステムにより ショートネック症例において正確な位置決めを可能にします 1. ZONE-2 and Short Neck 独自のベアステント構造 外骨格 シーリング サポート ステントにより ショートネック症例への留置を実現
JHN Journal Club 手稲渓仁会病院
JHOSPITALIST network GUIDE-IT trial; The Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure multicentre randomised clinical trial 20171010 1 70 (EF 30%), (PCI), (HbA1c
Table 1 Characteristics of the study participants in Imari municipal hospital
Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin
JA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
untitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
198 Table 1a Preoperative patients characteristics (EVH group) Age (y.o) Gender Comorbidity Lesion TASC II Fontaine 51 male HTN, HPL, DM, smoking Lt S
Online publication November 10, 2013 197 原 著 FP endoscopic vein harvest; EVH 要旨 : 2005 1 endoscopic vein harvest EVH 2007 8 femoro-popliteal bypass; FP EVH 2012 12 12 12 EVH J Jpn Coll Angiol 2013; 53:
1
1 5% 4% 11% 8% 13% 12% 10% 6% 17% 6% 8% 4% 6% 6% 2% 17% 17% 12% 14% 16% 6% 37% 11% 17% 35% 2 (N=6,239) 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 1,585 1,126 950 494 345 296 242 263 191 150 131 116
胆石症
,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic
244 HLHS HLHS はじめに HLHS HLHS ASD BAS ASD 2 Bil-PAB PGE1 Bil-PAB 3 BAS Norwood-Glenn 症例 1 29 HLHS ,536 g NICU 2 44 cm 2,536 g 54/34 mmh
症例報告 PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 26 NO. 3 (243 248) ハイリスク左心低形成症候群 (HLHS) に対する心臓カテーテル法による 2 つのステント同時留置術の経験 1 1 1 1 1 1 1 2 3 1 2 3 Key words: hypoplastic left heart syndrome, stent implantation,
untitled
19 CSPOR CRC/2009.8.8-9 2009 8 8 ( ) - CSPOR CRC SEMINAR- [email protected] http://www.oncoloplan.com - Toru Watanabe MD - 2 Phase I: Dose Finding trial Phase II : Efficacy and Safety trial Phase
CHEMOTHERAPY FEB Table 1 Background of volunteers
CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels
Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )
Gynecologic Oncology Trial and Investigation Consortium GOTIC-002
Gynecologic Oncology Trial and Investigation Consortium GOTIC-002 3 8 ...2...2...2...2...3...4...4...5...9...9...9...9...9... 13... 13... 13... 13... 13... 13... 13... 14... 14... 15... 15... 15...
診療ガイドラインのカラクリ
EBM EBM 2-3 (evidence-based medicine: EBM) EBM 1 1 1 2 B burden belief bargain barrier A. JAMA EBMer JAMA EBM 3 EBM 3 EBM 3 3 B. peer review Field(IOM) Shaneyfelt ( Guidelines Qualities Assessment Questionnaire:
症例 生来健康な 54 歳女性 現病歴 急性発症のめまいと歩行障害で救急搬送 頭部 MRIで右小脳半球 PICA 領域の一部に 急性期脳梗塞あり入院 アスピリン開始 急性期管理を行いつつ 脳梗塞の原因検索を開始した
Clinical Question 2014 年 9 月 29 日 J Hospitalist Network 心房中隔壁異常を伴う Cryptogenic Stroke の再発予防 東京ベイ 浦安市川医療センター総合内科原谷浩司監修江原淳 分野 : 神経 テーマ : 治療 症例 生来健康な 54 歳女性 現病歴 急性発症のめまいと歩行障害で救急搬送 頭部 MRIで右小脳半球 PICA 領域の一部に
終末期癌患者に対する 輸液治療の是非
3 A B NSAID D Case stories A B NSAID D Case stories A. IASP Task Force on Taxonomy WHO Collaborating Center for Palliative Cancer Care : Looking forward to cancer pain relief for all. CBC Oxford, Oxford,
PowerPoint プレゼンテーション
ACP Japan 2014 論文 30 選 神経内科 感染症編 山田康博 東京医療センター総合内科 2014 年 5 月 31 日 Effects of Immediate Blood Pressure Reduction on Death and Major Disability in patients With Acute Ischemic Stroke The CATIS Randomized
ê ê ê 2007 ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê b b b b b b b b b b b ê ê ê b b b b ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê b